hrp0086wg2.2 | ESPE Obesity Working Group (OWG) | ESPE2016
hrp0082fc7.4 | Growth promoting therapies | ESPE2014
hrp0095p1-296 | GH and IGFs | ESPE2022
Ly Helena-Jamin , Fors Hans , Dahlgren Jovanna
hrp0092p1-195 | Fat, Metabolism and Obesity (1) | ESPE2019
Dahlgren Jovanna , Kjellberg Emma , Roswall Josefine
hrp0084p3-750 | Diabetes | ESPE2015
Kintis Thomas , Marild Staffan , Dahlgren Jovanna
hrp0095p1-84 | Fat, Metabolism and Obesity | ESPE2022
Berggren Sara , Dahlgren Jovanna , Andersson Ola , Bergman Stefan , Roswall Josefine
hrp0092rfc11.4 | Pituitary, Neuroendocrinology and Puberty Session 2 | ESPE2019
Kvernebo-Sunnergren Kjersti , Ankarberg-Lindgren Carina , Dahlgren Jovanna
hrp0089p1-p138 | Fetal, Neonatal Endocrinology and Metabolism P1 | ESPE2018
Allvin Kerstin , Dahlgren Jovanna , Andersson Mats X , Ankarberg-Lindgren Carina
hrp0086p1-p811 | Syndromes: Mechanisms and Management P1 | ESPE2016
Kvernebo-Sunnergren Kjersti , Ankarberg-Lindgren Carina , AEkesson Karin , Dahlgren Jovanna
hrp0082p2-d1-372 | Fat Metabolism & Obesity | ESPE2014
Roswall Josefine , Kjellberg Emma , Strandvik Birgitta , Dahlgren Jovanna